SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-011389
Filing Date
2024-02-05
Accepted
2024-02-05 18:02:20
Documents
1
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7276
  Complete submission text file 0000950170-24-011389.txt   8805
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INTER-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET NEW YORK NY 10016
Business Address
Durgam Suresh K. (Reporting) CIK: 0001829958 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36274 | Film No.: 24597210